Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
Jinnin M et al
InChi: InChI=1S/C20H15ClF3N5
5-dihydroxy-
Salituro FG
In GDC-0879 treated mice
TAK-779 Catalog No.:M10030-10 Jinnin M et alTAK 779 is a C C chemokine receptor type 5 (CCR5) receptor antagonist potentially for the treatment of HIV infection. Treatment with TAK 779 reduced incidence and severity of experimental autoimmune encephalomyelitis. It strongly inhibited migration of CXCR3 CCR5 bearing CD4+, CD8+ and CD11b+ leukocytes to the CNS. TAK 779 did not reduce proliferation of anti myelin oligodendrocyte glycoprotein T cells, the production of IFN gamma by T cells or CXCR3